Supplements October 8, 2024 2024 Rare Neurological Disease Special Report October 8, 2024 October 8, 2024 MDedge Neurology September 4, 2024 Pulmonology Data Trends 2024 September 4, 2024 September 4, 2024 MDedge Internal Medicine August 14, 2024 Federal Health Care Data Trends 2024 August 14, 2024 August 14, 2024 Federal Practitioner July 15, 2024 A Second-line Option for Previously Treated Radioiodine-Refractory Differentiated Thyroid Cancer (DTC) July 15, 2024 Jameel Muzaffar, MD Jameel Muzaffar, MDJuly 15, 2024 Federal Practitioner More
October 8, 2024 2024 Rare Neurological Disease Special Report October 8, 2024 October 8, 2024 MDedge Neurology
September 4, 2024 Pulmonology Data Trends 2024 September 4, 2024 September 4, 2024 MDedge Internal Medicine
August 14, 2024 Federal Health Care Data Trends 2024 August 14, 2024 August 14, 2024 Federal Practitioner
July 15, 2024 A Second-line Option for Previously Treated Radioiodine-Refractory Differentiated Thyroid Cancer (DTC) July 15, 2024 Jameel Muzaffar, MD Jameel Muzaffar, MDJuly 15, 2024 Federal Practitioner
